Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pain block beats standard injection after gallbladder surgery

NCT ID NCT07176299

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested different ways to control pain after laparoscopic gallbladder removal in 160 adults. Patients received either a TAP block (an injection into the abdominal wall muscles), local anesthetic at the incision sites, both, or no extra pain relief. The TAP block group reported less pain and had fewer wound problems in the first 24 hours after surgery, suggesting it is a safe and effective option.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If this method proves better, it could become a standard way to manage pain after gallbladder surgery, reducing the need for strong painkillers.
What could go wrong
This is a completed study, so results are final. However, it only looked at short-term pain up to 24 hours, and the benefits may not apply to other surgeries or longer recovery periods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

160 people

The number who actually took part.

Started

Sep 2021

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 20 to 85 years * Scheduled for elective laparoscopic cholecystectomy for symptomatic cholelithiasis confirmed by ultrasonography * American Society of Anesthesiologists (ASA) physical status I-II * Provided written informed consent Exclusion Criteria: * ASA physical status III-IV * Contraindications to laparoscopy * Acute cholecystitis diagnosed preoperatively or perioperatively * Chronic analgesic use * Spinal degenerative joint disease * Known allergy to local anesthetics * Opioid or alcohol dependence * Psychiatric or neurological disorders * Lack of consent or withdrawal of consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia, local are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cholelithiasis Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Clinical Hospital in Olsztyn

    Olsztyn, Warmian-Masurian Voivodeship, 11-041, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.